(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

EPIMED

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

EPIMED

ST13

US500000085328059

Class

9, 10, 42

Filing

85328059

Registration

4192854

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

26

Latest update

12/21/2022

Trademark type

Word

Nice classes

9, 10, 42

Filing date

05/23/2011

Registration date

08/21/2012

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

12/21/2022

Last transaction

12/21/2022

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

First use anywhere

01/01/1997

First use in commerce

01/01/1997

Drawing code

4

Owner type

03

Owner location

Farmers Branch, TX, US

Examiner

BUSH, KAREN K

Law office

L80

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

EPIMED INTERNATIONAL, INC.
EPIMED INTERNATIONAL, INC.

Representatives

James C. Watson Traskbritt, P.C.

Technical classification

Nice Classes

Class 9Class 10Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 9

Clothing for protection against radiation; Radiation resistant gloves; Protective eyewear

Class 10

Catheters and parts and fittings therefor; Needles for medical use; Epidural needles; Medical needles and introducers; Injection instruments with needles; Injection needles; Electrotherapy devices for providing electrical nerve stimulation; Infusion sets; Medical apparatusinfusion and injection devices for administering drugs; Medical devicessurgical devices that facilitate the ablation of biological tissues; Cannulas; all of the foregoing specifically excluding prefilled epinephrine auto-injectors and syringes

Class 42

Research and development in the field of pain management and anesthesia

Publications

History of USPTO decisions and trademark events.

26 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

12/21/2022

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

12/21/2022

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

12/21/2022

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

12/21/2022

E89R

TEAS SECTION 8 & 9 RECEIVED

06/07/2022

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

08/21/2021

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

08/29/2018

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

08/29/2018

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

08/29/2018

E815

TEAS SECTION 8 & 15 RECEIVED

08/20/2018

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

08/21/2017

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

04/18/2013

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

04/18/2013

R.PR

REGISTERED-PRINCIPAL REGISTER

08/21/2012

TMBN

TTAB RELEASE CASE TO TRADEMARKS

07/12/2012

OP.T

OPPOSITION TERMINATED NO. 999999

07/12/2012

OP.D

OPPOSITION DISMISSED NO. 999999

07/12/2012

MAIL

PAPER RECEIVED

06/14/2012

OP.I

OPPOSITION INSTITUTED NO. 999999

04/13/2012

ETOF

EXTENSION OF TIME TO OPPOSE RECEIVED

11/10/2011

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

10/18/2011

PUBO

PUBLISHED FOR OPPOSITION

10/18/2011

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

09/13/2011

DOCK

ASSIGNED TO EXAMINER

09/08/2011

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

05/27/2011

NWAP

NEW APPLICATION ENTERED

05/26/2011

Continuous trademark protection

Get notified about every new filing that threatens EPIMED or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.